Theraclion SA (EPA:ALTHE)
France · Delayed Price · Currency is EUR 0.5850
+0.0450 (8.33%)
Oct 22, 2026, 5:35 PM CEST
Theraclion Revenue
Theraclion had revenue of 663.00K EUR in the half year ending June 30, 2026, with 131.01% growth. In the year 2025, Theraclion had annual revenue of 1.19M with 42.89% growth. That makes Theraclion the 44,423rd largest company in the world by revenue and 598th in France.
Revenue
1.19M
Revenue Growth
+42.89%
P/S Ratio
89.10
Revenue / Employee
13.33K
Employees
40
Market Cap
42.77M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.19M | 356.00K | 42.89% |
| Dec 31, 2024 | 830.00K | -992.22K | -54.45% |
| Dec 31, 2023 | 1.82M | 586.77K | 47.49% |
| Dec 31, 2022 | 1.24M | -245.50K | -16.58% |
| Dec 31, 2021 | 1.48M | 736.95K | 99.05% |
| Dec 31, 2020 | 744.00K | -2.04M | -73.27% |
| Dec 31, 2019 | 2.78M | 854.46K | 44.30% |
| Dec 31, 2018 | 1.93M | -502.09K | -20.65% |
| Dec 31, 2017 | 2.43M | 2.36M | 3,399.13% |
| Dec 31, 2016 | 69.47K | -1.38M | -95.21% |
| Dec 31, 2015 | 1.45M | 649.40K | 81.21% |
| Dec 31, 2014 | 799.69K | 785.19K | 5,415.10% |
| Dec 31, 2013 | 14.50K | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Guerbet | 790.65M |
| Eurobio Scientific Société anonyme | 172.26M |
| Biosynex | 95.19M |
| Diagnostic Medical Systems | 51.41M |
| Novacyt | 25.31M |
| Median Technologies | 23.47M |
| Implanet | 13.80M |
| Mauna Kea Technologies | 8.38M |